BERLIN B2B
INTERNATIONAL CANNABIS BUSINESS CONFERENCE
BERLIN 2021 SCHEDULE
26-27 AUGUST 2021
THURSDAY, 26 AUGUST 2021
Alex Rogers, Executive Producer of the International Cannabis Business Conference, welcomes conference attendees and provides an overview of the conference schedule, including the panels and speakers that will be providing presentations and interviews.
Alex Rogers
Jamie L. Pearson is the President & CEO of Bhang Inc. A rare, second-generation cannabis executive, she has decades of experience in global operations, deal structuring and negotiation as a former multi-national real estate entrepreneur and investor. Fluent in German and English, Jamie is responsible for Bhang's capital markets initiatives, national and international expansion, and overall corporate management. She leads the company's diverse executive team in the development and execution of Bhang's strategic plan.
Jamie Pearson
The latest and most important information regarding cannabis regulations in Europe
Peter Homberg, a partner at Dentons Law Firm, will provide a thorough update regarding medical cannabis regulations and trends in Germany and Europe. Topics will include supply and demand in Germany and Europe, the German tender process regarding national cultivation of medical cannabis, cannabis exports/imports, price models, and potential harmonization of cannabis products within the EU.
Peter Homberg
Cannabis for sale - the state of Europe's leading market
Jürgen Neumeyer
MANAGING DIRECTOR BRANCHENVERBAND CANNABISWIRTSCHAFT E.V. (BVCW)
Dr. Wieland Schinnenburg, MdB
MEMBER OF THE GERMAN BUNDESTAG, (FDP - LIBERAL PARTY)
Erwin Rüddel
CHAIRMAN OF THE GERMAN BUNDESTAG'S COMMITTEE ON HEALTH, (CDU)
Burkhard Blienert
FORMER MEMBER OF THE GERMAN BUNDESTAG, (SPD)
Niema Movassat
MEMBER OF THE GERMAN BUNDESTAG, (DIE LINKE)
Werner Graf
STATE CHAIRMAN BÜNDNIS 90/DIE GRÜNEN BERLIN, (GREEN PARTY)
Public policy experts representing all major political parties in Germany will participate in this panel discussion hosted by the German Cannabis Business Association (Branchenverband Cannabiswirtschaft e.V. - BvCW). The political framework of four key policy areas will be discussed. Topics will include the future of medical cannabis policy in Germany, hemp as a renewable resource, necessary framework conditions for CBD (and other cannabinoids), and anticipating needed changes after the upcoming federal election. This panel discussion will be held in German.
Pharmacies are the backbone of Germany's cannabis industry
Tobias Lau
JOURNALIST, EDITOR AT APOTHEKE ADHOC
Florian Heimann
CO-FOUNDER CANNABIS-APOTHEKE.DE
Sita Schubert
SECRETARY GENERAL, EUROPEAN MEDICINAL CANNABIS ASSOCIATION (EUMCA)
Melanie Dolfen
OWNER OF THE BEZIRKSAPOTHEKEN AND GESUNDBAR IN BERLIN
Four years after the introduction of medical cannabis in Germany the market continues to develop rapidly, and pharmacies and patients often struggle to keep up due to regulatory shortcomings and unnecessary restrictions. Pharmacies continue to serve as the main distributors of medical cannabis in Germany. This panel will discuss Germany's current distribution model, ways to improve performance and supply, and how adult-use cannabis legalization may impact medical cannabis distribution.
Obtaining shelf space in the marketplace
Xenia von Maltzan
CUSTOMER RELATIONS MANAGER, PROPHARMA GROUP
Cornelius Maurer
FOUNDER, DEMECAN
Alessandro Rossoni
CO-FOUNDER AND MANAGING DIRECTOR OF NIMBUS HEALTH
Tony Schroeter
BOARD MEMBER AND HEAD OF GROUP COMPLIANCE, WEECO HOLDING GMBH
Benedikt Sons
CO-FOUNDER AND CEO OF CANSATIVA
The German medical cannabis market is one of the most valuable in the world - but unique challenges exist in navigating it successfully. Learn from the experts about what it takes to get your cannabis and products into the market and what leads to ongoing sales strategies that work.
The most important information that you need to know about CBD regulations
Tobias Lau
JOURNALIST, EDITOR AT APOTHEKE ADHOC
Boštjan Jančar
CHIEF TECHNOLOGY OFFICER, PHARMAHEMP
Jan Peter Witte
MANAGING DIRECTOR VAYAMED AND DIRECTOR MEDICAL SANITY GROUP
Sebastian Kamphorst
CO-FOUNDER & CEO BECANEX GmbH
The last two years have been a roller coaster ride for companies selling and developing CBD products – from the EU officially considering CBD as a narcotic, to its highest court ruling that it is exactly not a narcotic. Now the trend points to the liberalization of CBD regulation, which provides new opportunities for those companies but also opens up some new challenges. So where is the CBD market going? How does regulation still need to be reformed? How can providers of CBD products in pharmaceutical quality position themselves?
Streamlining rules and regulations in the midst of an evolving industry
Benjamin Patock
HEAD OF INTERNATIONAL RELATIONS, BOVEDA
Lewis Koski
CHIEF OPERATING OFFICER, METRC
Luc Richner
CEO FOUNDER, CANNAVIGIA
Daniel McMillan
SCIEX SR MARKET DEVELOPMENT MANAGER - FOOD, ENVIRONMENT & FORENSIC - EMEAI
The international industry requires homogenization of standards to continue to flourish. This includes between continents, but it also includes regions like Europe, and after federal reform, the United States. How does the industry achieve this in an environment where legalization is still moving forward at different stages of maturity, and where to start?
Harmonization of global medical standards through the eyes of cannabusiness experts
Michael Knodt
CEO SWISS HEMPCARE
Nima Kaempf
CEO CHARLIE'S LAB AND SWISS HEMPCARE
Peter Sigetty
COO, VALCON MEDICAL
GMP is one of the largest issues facing the international medical and increasingly recreational market. Uniform GMP legislation already exists in Europe. For companies aiming to enter the European cannabis market, EU-GMP is essential. What are the chances and problems seen by consultants and regulators as GMP regulations are homogenized within the EU, but differ across international borders?
Bringing new and innovative cannabis food products to the EU
Lisa Haag
FOUNDER MJ_UNIVERSE
Kai-Friedrich Niermann
KFN+ LAW OFFICE, FOUNDER
Francis Scanlan
FOUNDER AND MANAGING DIRECTOR, CLOUD 9 SWITZERLAND LLC
Marjeta Česen
CHIEF REGULATORY AFFAIRS OFFICER, PHARMAHEMP
What is "Novel Food" legislation and how are companies today in Europe and UK successfully finding a path to market within this stricture? What are the outstanding issues and how will this also affect the recreational THC market in Switzerland and Luxembourg as of next year?
Protecting your concept in a hyper-competitive industry
What are the challenges in advertising cannabis and CBD products in Germany?How do you trademark your Cannabis brand in Germany and Europe? What are the key points for brand protection?
Margret Knitter
What is the current status of the EU cannabis market and where is the market headed?
Demand for legal cannabis products is ramping up as cannabis reform continues to spread across the European continent. This presentation led by top cannabis industry economist Beau Whitney will highlight the various legalization initiatives in the EU as well as provide a snapshot of the current CBD and THC markets in various European countries. Whitney will also provide a forecast of what to expect in the emerging legal cannabis market in Europe in the coming years.
Beau Whitney
Demand for legal cannabis products is ramping up as cannMatthew Nordgren, Founder and Managing Partner of Arcadian Capital, a venture capital firm investing in the ancillary sector of the cannabis industry, will be giving a 20-minute presentation on his expertise in investing in cannabis and hemp companies, the strategy he believes is the most ideal in the cannabis space, and projections for the next few years. This presentation will give the audience insight on the investment landscape of the cannabis industry, the milestones to come, and where it is headed in the US and globally.
Matthew Nordgren
FRIDAY, 27 AUGUST 2021
The latest and most important information regarding cannabis regulations in Europe
Identifying and properly analyzing emerging cannabis industry trends can provide valuable insight that could help change the trajectory of a cannabis company. Giadha A. DeCarcer, founder and executive chair of New Frontier Data, will discuss macro trends in the cannabis industry, focusing on non-endemic brands entering the space and implications for investment, consolidation and consumer engagement. DeCarcer is an entrepreneur with over 20 years of experience in business execution, management, and strategic business development.
Giadha DeCarcer
How to Navigate the Complex and Competitive Landscape of the EU and Global Cannabis Markets to Succeed and Thrive
As the EU and global market recovers and expands post-pandemic, fantastic business opportunities are opening up with new licensed medical operations, the Dutch Weed Experiment, ancillary markets and investments, and the hemp sector. International laws are essentially the referees of the game, and it is imperative that as new doors open, businesses stay compliant with the ever-evolving regulations and GXP standards for cultivation, processing and manufacturing of consumer packaged goods, as well as the global importation and exportation of these products. Join Nic Easley, CEO of 3C Consulting and Managing Director of Multiverse Capital, as he coaches entrepreneurs and investors with strategic plays that he’s executed for over a decade on the inside of the operational and investment arenas of the global industry. Nic will share techniques for raising capital, starting new businesses, and investing in the areas with the most potential for long-term success. Nic will also explore the trends throughout Germany, Europe, and other international markets and educate you from the playbooks of North American and International successes and failures.
Nic Easley
Making a global splash in the emerging international cannabis industry
Michael Knodt
FREELANCE JOURNALIST
Rodolphe Ruffie
SENIOR ASSOCIATE, CLIFFORD CHANCE
Pete Patterson
CEO, VALCON MEDICAL
The cannabis industry is now fully international. Biomass and products are being shipped globally. However, this is one of the most difficult and complicated parts of the entire industry. Learn from the experts what it takes to enter the international industry and what the biggest challenges still are in shipping cannabinoids across borders.
Which markets in Europe have the most potential and opportunity?
Marguerite Arnold
ENTREPRENEUR, INFLUENCER, JOURNALIST
Stephen Murphy
CEO AND CO-FOUNDER OF PROHIBITION HOLDINGS
Kostas Ioannou
BUSINESS DEVELOPMENT REPRESENTATIVE, VITALIS EXTRACTION TECHNOLOGY
Boniface Dube
BIONOMINAL COEFFICIENTS GROUP (BCG)
Paul Smerda
BUSINESS DEVELOPMENT MANAGER, NEW ZEALAND TRADE AND ENTERPRISE
Add cannabis to emerging market dynamics and you have the recipe for economic development on steroids. Learn from the experts about what is going on in places like Poland, Greece and other emerging markets that are also on the brink of cannabis reform.
Reducing the stigma of a proven medicine
Moritz Förster
FOUNDER KRAUTINVEST.DE and PR-LEAD AT OPENERS
Daniel Gauci
CHIEF BUSINESS DEVELOPMENT OFFICER, HEAD OF CONTENT, JUICY FIELDS
Božidar Radišic
CHIEF BUSINESS DEVELOPMENT OFFICER, HEAD OF CONTENT, JUICY FIELDS
Julian Wichmann
FOUNDER & CEO, ALGEA CARE
Doctor education has finally started to come to Europe - but what exactly does this mean? Beyond doctors however, what else is necessary from the industry to change perceptions of the plant and cannabinoid medicines - and at all levels - from national governments to municipal leaders, not to mention patients, insurers, and regulators?
What will cannabis legalization look like in Germany?
Rebecca Wiegärtner
FOOD & RETAIL BUSINESS CONSULTANT
Lisa Haag
FOUNDER MJ_UNIVERSE
Jan Witte
MANAGING DIRECTOR VAYAMED AND DIRECTOR MEDICAL SANITY GROUP
Burkhard Blienert
FORMER MEMBER OF THE GERMAN BUNDESTAG, (SPD)
Germany is at the brink of getting a new government, and the word is that it will most probably include the Green Party. Therefore, the prospects for the legalization of recreational Cannabis use have never been better than now. But if so – then how? Most probably Germany would start with at least some kind of pilot projects like distribution via pharmacies and then end up in some highly regulated market. So, what are the role models for legalization German lawmakers look at? What can Cannabis companies expect? And how should they prepare for it?
Revolutionizing an Emerging Industry
Marguerite Arnold
COFOUNDER, MEDPAYRX AND CANNACLEAR
Ziya Gaziyev
FOUNDER AND CEO OF HELLOMARY
Marc Plinke
OWNER, CERES GREENHOUSE SOLUTIONS
Lucas Targos
VICE PRESIDENT OF
FACILITY INTEGRATION
URBAN-GRO, INC.
Tobias Meller
FOUNDER TINY TECHNOLOGIES GmbH
Cannatech. Technology and cannabis are continuing to merge. In Europe this falls under both the rubric of digital healthcare as well as certification, production and processing procedures (like GMP). Find out what some of the bigger issues are across the European and British cannatech space as well as some of the companies which are stepping up to meet the challenge.
Making sure that the industry has a seat at the table
Clinton Younge
PRESIDENT, CHARLIE'S PHARMACY
Michael Correia
DIRECTOR OF GOVERNMENT RELATIONS FOR THE NATIONAL CANNABIS INDUSTRY ASSOCIATION
Georg Wurth
LEADER OF THE GERMAN HEMP ASSOCIATION (DHV)
Finn Hänsel
FOUNDER AND MANAGING DIRECTOR OF SANITY GROUP, MD
Marijn Roersch van der Hoogte
VICE PRESIDENT, GERMAN CANNABIS BUSINESS ASSOCIATION
New cannabis rules, regulations, and laws are being crafted all over the globe right now, and in jurisdictions where the cannabis industry is already allowed to legally operate policy updates are being drafted and implemented on an ongoing basis. It is absolutely vital that the emerging cannabis industry has a voice in every policy discussion to ensure that the industry's concerns and needs are properly conveyed to policymakers and industry regulators. This panel of cannabis lobbying experts will discuss the importance of cannabis industry lobbying as well as provide guidance regarding how to be an effective lobbyist.
From Taboo to Typical
Shane MacGuill
GLOBAL LEAD - NICOTINE AND CANNABIS, EUROMONITOR INTERNATIONAL
Spiros Malandrakis
HEAD OF RESEARCH – ALCOHOLIC DRINKS AND CANNABIS, EUROMONITOR INTERNATIONAL
Beyond the haze of hype and dramatic share price fluctuations, the cannabis industry is incrementally penetrating into the realms of FMCG through geographic expansion, democratisation and the adoption of innovative formats and branding sophistication. This session will explore the future evolution of the global cannabis industry - as it sheds its mantle of illicit associations - across markets, consumers and brand propositions. Leveraging proprietary data, deep industry and FMCG expertise, expect a roadmap and vision for the emerging market opportunities, demographic profiles and lifestyle positioning which will shape global cannabis as it comes of age.
Getting positive attention for your innovative concepts
Michael Knodt
FREELANCE JOURNALIST
Petra Marinko
FOUNDER AND OWNER, PHARMA G, NABIE
Mike Wise
FILMMAKER, PUBLIC SPEAKER, GONZO JOURNALIST,
MEDICINE MAN
Jurij Butina
COO, SNAIL CUSTOM ROLLING PAPERS
Stand out, be different, be unique. How important is the visual part of identity, what are psychological aspects and how important is product placement? Useful design and marketing tips and tricks can help you persuade your customers to buy your products or services instead of your competitors. Mass market, online stores, drug stores, B2B, B2C, private label, white label all require different approaches. Our panel of marketing and design experts break down the key aspects of how you can distinguish your brand from every other.
